[Plasma cell leukemia resistant to chemotherapy, with special reference to cytogenetic markers, 14q+ and double minute chromosomes]. 1984

Y Yamane, and J Edagawa, and K Nishida, and S Tsuda, and T Maekawa, and M Taniwaki, and Y Sonoda, and S Misawa, and T Abe, and T Takino

UI MeSH Term Description Entries
D007952 Leukemia, Plasma Cell A rare, aggressive variant of MULTIPLE MYELOMA characterized by the circulation of excessive PLASMA CELLS in the peripheral blood. It can be a primary manifestation of multiple myeloma or develop as a terminal complication during the disease. Leukemia, Plasmacytic,Plasma Cell Leukemia,Plasmacytic Leukemia,Leukemias, Plasma Cell,Leukemias, Plasmacytic,Plasma Cell Leukemias,Plasmacytic Leukemias
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D002901 Chromosomes, Human, 13-15 The medium-sized, acrocentric human chromosomes, called group D in the human chromosome classification. This group consists of chromosome pairs 13, 14, and 15. Chromosomes D,Group D Chromosomes,Chromosome, Group D,Chromosomes, Group D,Group D Chromosome
D005260 Female Females
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

Y Yamane, and J Edagawa, and K Nishida, and S Tsuda, and T Maekawa, and M Taniwaki, and Y Sonoda, and S Misawa, and T Abe, and T Takino
January 1981, Cytogenetics and cell genetics,
Y Yamane, and J Edagawa, and K Nishida, and S Tsuda, and T Maekawa, and M Taniwaki, and Y Sonoda, and S Misawa, and T Abe, and T Takino
January 2011, Asian Pacific journal of cancer prevention : APJCP,
Y Yamane, and J Edagawa, and K Nishida, and S Tsuda, and T Maekawa, and M Taniwaki, and Y Sonoda, and S Misawa, and T Abe, and T Takino
April 2020, Cancer genetics,
Y Yamane, and J Edagawa, and K Nishida, and S Tsuda, and T Maekawa, and M Taniwaki, and Y Sonoda, and S Misawa, and T Abe, and T Takino
November 1982, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Y Yamane, and J Edagawa, and K Nishida, and S Tsuda, and T Maekawa, and M Taniwaki, and Y Sonoda, and S Misawa, and T Abe, and T Takino
September 1980, The New England journal of medicine,
Y Yamane, and J Edagawa, and K Nishida, and S Tsuda, and T Maekawa, and M Taniwaki, and Y Sonoda, and S Misawa, and T Abe, and T Takino
May 1985, Journal of the National Cancer Institute,
Y Yamane, and J Edagawa, and K Nishida, and S Tsuda, and T Maekawa, and M Taniwaki, and Y Sonoda, and S Misawa, and T Abe, and T Takino
October 1994, Cancer genetics and cytogenetics,
Y Yamane, and J Edagawa, and K Nishida, and S Tsuda, and T Maekawa, and M Taniwaki, and Y Sonoda, and S Misawa, and T Abe, and T Takino
August 1993, Cancer genetics and cytogenetics,
Y Yamane, and J Edagawa, and K Nishida, and S Tsuda, and T Maekawa, and M Taniwaki, and Y Sonoda, and S Misawa, and T Abe, and T Takino
March 1987, Cancer genetics and cytogenetics,
Y Yamane, and J Edagawa, and K Nishida, and S Tsuda, and T Maekawa, and M Taniwaki, and Y Sonoda, and S Misawa, and T Abe, and T Takino
February 2011, Journal of applied genetics,
Copied contents to your clipboard!